Reviva Pharmaceuticals Hldg Inc
(RVPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 02-2020 | 12-2019 | 11-2019 | 08-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 69 | 0 | 134 | 211 |
| TOTAL | $N/A | $139 | $0 | $150 | $250 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 1 | N/A | N/A |
| Investments And Advances | 0 | 60,883 | 0 | 66,323 | 66,020 |
| Other Non-Current Assets | 0 | 0 | 2 | 0 | 0 |
| TOTAL | $N/A | $60,883 | $2 | $66,323 | $66,020 |
| Total Assets | $N/A | $61,022 | $3 | $66,473 | $66,270 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 3,765 | N/A | N/A |
| Accounts payable and accrued liabilities | 0 | 300 | 225 | 100 | 34 |
| Accrued Expenses | N/A | N/A | 2,723 | N/A | N/A |
| Other current liabilities | N/A | N/A | 102 | N/A | N/A |
| TOTAL | $N/A | $300 | $6,814 | $100 | $34 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 55,722 | 0 | 61,373 | 61,236 |
| TOTAL | $N/A | $55,722 | $N/A | $61,373 | $61,236 |
| Total Liabilities | $N/A | $56,022 | $6,814 | $61,473 | $61,270 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 8,265 | 8,265 |
| Common Shares | N/A | 3,808 | 1 | 3,676 | 3,813 |
| Retained earnings | N/A | 1,192 | -54,527 | 1,324 | 1,187 |
| Other shareholders' equity | 0 | 0 | 29,070 | 0 | 0 |
| TOTAL | $N/A | $5,000 | $-6,811 | $5,000 | $5,000 |
| Total Liabilities And Equity | $0 | $61,022 | $3 | $66,473 | $66,270 |